Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Stopping GLP-1 drugs can quickly erase cardiovascular benefits Even brief interruption tied to change in risk of heart attack, stroke and death Sara Moser and Alaska Adams / WashU Medicine Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S
Achieving full sovereignty with your health means making decisions grounded in real evidence
Els cids grassos lliures en el citosol s'ajunten al coenzima A mitjanant enllaos tioester
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets
This months content spans a remarkable breadth of analytical Your Peak Insights: Smarter Chromatography Across Food, Biopharma, and AI May 28, 2026 Your Peak Insights: Smarter Chromatography Across Food, Biopharma, and AI Welcome to your May edition of Peak Insights
US$ 21.88
US$ 21.16
US$ 28.13
US$ 25.51
US$ 20.11
US$ 28.73
US$ 21.77
